Immunotherapies targeting CD38 in Multiple Myeloma

nork Atanackovic, Djordje, Steinbach, Mary, Radhakrishnan, Sabarinath Venniyil, Luetkens, Tim
Argitaratua izan da Oncoimmunology (2016)

Novel anti-myeloma immunotherapies targeting the SLAM family of receptors

nork Radhakrishnan, Sabarinath Venniyil, Bhardwaj, Neelam, Luetkens, Tim, Atanackovic, Djordje
Argitaratua izan da Oncoimmunology (2017)

Prognostic and Diagnostic Value of Spontaneous Tumor-Related Antibodies

nork Kobold, Sebastian, Luetkens, Tim, Cao, Yanran, Bokemeyer, Carsten, Atanackovic, Djordje
Argitaratua 2010

Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation

nork Templin, Julia, Atanackovic, Djordje, Hasche, Daniel, Radhakrishnan, Sabarinath Venniyil, Luetkens, Tim
Argitaratua izan da Oncotarget (2017)

Role of immunotherapy in Ewing sarcoma

nork Morales, Erin, Olson, Michael, Iglesias, Fiorella, Dahiya, Saurabh, Luetkens, Tim, Atanackovic, Djordje
Argitaratua izan da J Immunother Cancer (2020)

Elotuzumab as a novel anti-myeloma immunotherapy

nork Radhakrishnan, Sabarinath Venniyil, Bhardwaj, Neelam, Steinbach, Mary, Weidner, Janet, Luetkens, Tim, Atanackovic, Djordje
Argitaratua izan da Hum Vaccin Immunother (2017)

Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma

nork Yousef, Sara, Heise, Johanna, Lajmi, Nesrine, Bartels, Katrin, Kröger, Nicolaus, Luetkens, Tim, Atanackovic, Djordje
Argitaratua izan da J Transl Med (2015)

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma

nork Hendrickson, Peter G., Olson, Michael, Luetkens, Tim, Weston, Siani, Han, Tiffany, Atanackovic, Djordje, Fine, Gabriel C.
Argitaratua izan da Oncoimmunology (2019)

5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity

nork Stübig, Thomas, Badbaran, Anita, Luetkens, Tim, Hildebrandt, York, Atanackovic, Djordje, Binder, Thomas M. C., Fehse, Boris, Kröger, Nicolaus
Argitaratua 2014

CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma

nork Yousef, Sara, Kovacsovics-Bankowski, Magdalena, Salama, Mohamed E, Bhardwaj, Neelam, Steinbach, Mary, Langemo, Amanda, Kovacsovics, Tibor, Marvin, James, Binder, Mascha, Panse, Jens, Kröger, Nicolaus, Luetkens, Tim, Atanackovic, Djordje
Argitaratua izan da Hum Vaccin Immunother (2015)

Longitudinal Analysis of Tetanus- and Influenza-Specific IgG Antibodies in Myeloma Patients

nork Kobold, Sebastian, Luetkens, Tim, Bartels, Britta Marlen, Cao, Yanran, Hildebrandt, York, Sezer, Orhan, Reinhard, Henrike, Templin, Julia, Bartels, Katrin, Lajmi, Nesrine, Haag, Friedrich, Bokemeyer, Carsten, Kröger, Nicolaus, Atanackovic, Djordje
Argitaratua 2012

Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells

nork Atanackovic, Djordje, Hildebrandt, York, Jadczak, Adam, Cao, Yanran, Luetkens, Tim, Meyer, Sabrina, Kobold, Sebastian, Bartels, Katrin, Pabst, Caroline, Lajmi, Nesrine, Gordic, Maja, Stahl, Tanja, Zander, Axel R., Bokemeyer, Carsten, Kröger, Nicolaus
Argitaratua 2010

Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation

nork Kobold, Sebastian, Tams, Sinje, Luetkens, Tim, Cao, Yanran, Sezer, Orhan, Bartels, Britta Marlen, Reinhard, Henrike, Templin, Julia, Bartels, Katrin, Hildebrandt, York, Lajmi, Nesrine, Marx, Andreas, Haag, Friedrich, Bokemeyer, Carsten, Kröger, Nicolaus, Atanackovic, Djordje
Argitaratua 2011

Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant

nork Atanackovic, Djordje, Luetkens, Tim, Avila, Stephanie V., Hardy, Nancy M., Lutfi, Forat, Sanchez-Petitto, Gabriela, Vander Mause, Erica, Glynn, Nicole, Mannuel, Heather D., Alkhaldi, Hanan, Hankey, Kim, Baddley, John, Dahiya, Saurabh, Rapoport, Aaron P.
Argitaratua izan da Vaccines (Basel) (2021)

CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide

nork Radhakrishnan, Sabarinath V., Luetkens, Tim, Scherer, Sandra D., Davis, Patricia, Vander Mause, Erica R., Olson, Michael L., Yousef, Sara, Panse, Jens, Abdiche, Yasmina, Li, K. David, Miles, Rodney R., Matsui, William, Welm, Alana L., Atanackovic, Djordje
Argitaratua izan da Nat Commun (2020)

The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting

nork Atanackovic, Djordje, Reinhard, Henrike, Meyer, Sabrina, Spöck, Stefanie, Grob, Tobias, Luetkens, Tim, Yousef, Sara, Cao, Yanran, Hildebrandt, York, Templin, Julia, Bartels, Katrin, Lajmi, Nesrine, Stoiber, Heribert, Kröger, Nicolaus, Atz, Judith, Seimetz, Diane, Izbicki, Jakob R, Bokemeyer, Carsten
Argitaratua 2013

Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19

nork Luetkens, Tim, Metcalf, Ryan, Planelles, Vicente, Zheng, Yue, Larragoite, Erin T., Spivak, Emily S., Spivak, Adam M., Steinbach, Mary, Blaylock, Robert C., Avila, Stephanie V., Hankey, Kim G., Martins, Thomas B., Slev, Patricia R., Mannuel, Heather D., Sajadi, Mohammad, Rapoport, Aaron P., Atanackovic, Djordje
Argitaratua izan da Blood Adv (2020)